Switch theme
Sign up to access all valuation multiples
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).
1961
18.1K+
LTM Revenue $2.7B
LTM EBITDA $429M
$2.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Diagnosticos America has a last 12-month revenue of $2.7B and a last 12-month EBITDA of $429M.
In the most recent fiscal year, Diagnosticos America achieved revenue of $2.7B and an EBITDA of $347M.
Diagnosticos America expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Diagnosticos America valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $2.5B | $2.7B | XXX | XXX | XXX |
| Gross Profit | $662M | $678M | XXX | XXX | XXX |
| Gross Margin | 27% | 25% | XXX | XXX | XXX |
| EBITDA | $365M | $347M | XXX | XXX | XXX |
| EBITDA Margin | 15% | 13% | XXX | XXX | XXX |
| Net Profit | -$67.4M | -$203M | XXX | XXX | XXX |
| Net Margin | -3% | -8% | XXX | XXX | XXX |
| Net Debt | $1.8B | $1.6B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Diagnosticos America's stock price is BRL 2 (or $0).
Diagnosticos America has current market cap of BRL 2.3B (or $396M), and EV of BRL 13.4B (or $2.3B).
See Diagnosticos America trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.3B | $396M | XXX | XXX | XXX | XXX | $-0.07 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Diagnosticos America has market cap of $396M and EV of $2.3B.
Diagnosticos America's trades at 0.9x LTM EV/Revenue multiple, and 5.4x LTM EBITDA.
Analysts estimate Diagnosticos America's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Diagnosticos America and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $2.3B | XXX | XXX | XXX |
| EV/Revenue | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 6.7x | XXX | XXX | XXX |
| P/E | -1.9x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -26.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpDiagnosticos America's NTM/LTM revenue growth is 7%
Diagnosticos America's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $31K for the same period.
Over next 12 months, Diagnosticos America's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Diagnosticos America's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Diagnosticos America and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -5% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 20% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $31K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 21% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 21% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Sonic Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Bangkok Dusit Medical Services | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Diagnosticos America acquired XXX companies to date.
Last acquisition by Diagnosticos America was XXXXXXXX, XXXXX XXXXX XXXXXX . Diagnosticos America acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Diagnosticos America founded? | Diagnosticos America was founded in 1961. |
| Where is Diagnosticos America headquartered? | Diagnosticos America is headquartered in Brazil. |
| How many employees does Diagnosticos America have? | As of today, Diagnosticos America has 18.1K+ employees. |
| Is Diagnosticos America publicy listed? | Yes, Diagnosticos America is a public company listed on BVMF. |
| What is the stock symbol of Diagnosticos America? | Diagnosticos America trades under DASA3 ticker. |
| When did Diagnosticos America go public? | Diagnosticos America went public in 2004. |
| Who are competitors of Diagnosticos America? | Similar companies to Diagnosticos America include e.g. Australian Clinical Labs, Healius, Integral Diagnostics, Sonic Healthcare. |
| What is the current market cap of Diagnosticos America? | Diagnosticos America's current market cap is $396M |
| What is the current revenue of Diagnosticos America? | Diagnosticos America's last 12-month revenue is $2.7B. |
| What is the current EBITDA of Diagnosticos America? | Diagnosticos America's last 12-month EBITDA is $429M. |
| What is the current EV/Revenue multiple of Diagnosticos America? | Current revenue multiple of Diagnosticos America is 0.9x. |
| What is the current EV/EBITDA multiple of Diagnosticos America? | Current EBITDA multiple of Diagnosticos America is 5.4x. |
| What is the current revenue growth of Diagnosticos America? | Diagnosticos America revenue growth between 2023 and 2024 was 8%. |
| Is Diagnosticos America profitable? | Yes, Diagnosticos America is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
